Angiotensinogen gene polymorphisms and food-intake behavior in young, normal female subjects in Japan

Nutrition

Volumn 29, Issue 1, 2013, Pages 60-65

  Sasaki, Miki ^a   Yamada, Kaoru ^b   Namba, Haruko ^b   Yoshinaga, Mariko ^a   Du, Dongdong ^a   Uehara, Yoshio ^a  

^a KYORITSU WOMEN'S UNIVERSITY   (Japan)

^b University of Tokyo   (Japan)

Author keywords

Angiotensinogen; Food preference; Gene polymorphism; Nutrients

Indexed keywords

ANGIOTENSIN; BETA 3 ADRENERGIC RECEPTOR; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE; FATTY ACID;

ADRENERGIC BETA 3 RECEPTOR GENE; ADULT; ANGIOTENSIN CONVERTING ENZYME GENE; ANGIOTENSIN GENE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FAT INTAKE; FEEDING BEHAVIOR; FEMALE; FOOD PREFERENCE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; INDEL MUTATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN INTAKE; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINO ACID SUBSTITUTION; ANGIOTENSINOGEN; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; DNA PROBES; EATING; ENERGY INTAKE; FEEDING BEHAVIOR; FEMALE; FOOD PREFERENCES; HUMANS; INDEL MUTATION; JAPAN; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-3; RENIN-ANGIOTENSIN SYSTEM; YOUNG ADULT;

EID: 84870789980     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.03.013     Document Type: Article

References (27)

1. Moller D.E., Kaufman K.D. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 2005, 56:45-62.
2. Lafontan M. Fat cells: afferent and efferent messages define new approaches to treat obesity. Annu Rev Pharmacol Toxicol 2005, 45:119-146.
3. Mykkänen L., Haffner S.M., Rönnemaa T., Bergman R.N., Laakso M. Low insulin sensitivity is associated with clustering of cardiovascular disease risk factors. Am J Epidemiol 1997, 146:315-321.
4. Savica V., Bellinghieri G., Kopple J.D. The effect of nutrition on blood pressure. Annu Rev Nutr 2010, 30:365-401.
5. Yugar-Toledo J.C., Martin J.F., Krieger J.E., Pereira A.C., Demacq C., Coelho O.R., et al. Gene variation in resistant hypertension: multilocus analysis of the angiotensin 1-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase genes. DNA Cell Biol 2011, 30:555-564.
6. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J.P., Arveiler D., et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992, 359:641-644.
7. Rudnicki M., Mayer G. Significance of genetic polymorphisms of the renin-angiotensin-aldosterone system in cardiovascular and renal disease. Pharmacogenomics 2009, 10:463-476.
8. Al-Mallah M., Khawaja O., Sinno M., Alzohaili O., Samra A.B. Do angiotensin converting enzyme inhibitors or angiotensin receptor blockers prevent diabetes mellitus? A meta-analysis. Cardiol J 2010, 17:448-456.
9. Hershon K.S. Mechanistic and clinical aspects of renin-angiotensin-aldosterone system blockade in the prevention of diabetes mellitus and cardiovascular disease. Endocr Pract 2011, 17:430-440.
10. Underwood P.C., Sun B., Williams J.S., Pojoga L.H., Raby B., Lasky-Su J., et al. The association of the angiotensinogen gene with insulin sensitivity in humans: a tagging single nucleotide polymorphism and haplotype approach. Metabolism 2011, 60:1150-1157.
11. Jayasooriya A.P., Mathai M.L., Walker L.L., Begg D.P., Denton D.A., Cameron-Smith D., et al. Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc Natl Acad Sci U S A 2008, 105:6531-6536.
12. Nakano-Tateno T., Shichiri M., Suzuki-Kemuriyama N., Tani Y., Izumiyama H., Hirata Y. Prolonged effects of intracerebroventricular angiotensin II on drinking, eating and locomotor behavior in mice. Regul Pept 2012, 173:86-92.
13. Ohinata K., Fujiwata Y., Shingo F., Masaru I., Masatsugu H., Yoshikawa M. Orally administered novokinin, an angiotensin AT2 receptor agonist, suppresses food intake via prostaglandin E2-dependent mechanism in mice. Peptides 2009, 30:1105-1108.
14. Umegaki H., Iimuro S., Araki A., Sakurai T., Iguchi A., Yoshimura Y., et al. Association of higher carbohydrate intake with depressive mood in elderly diabetic women. Nutr Neurosci 2009, 12:267-271.
15. Sone H., Yoshimura Y., Tanaka S., Iimuro S., Ohashi Y., Ito H., et al. Japan Diabetes Complications Study (JDCS) Group: cross-sectional association between BMI, glycemic control and energy intake in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract 2007, 77(suppl 1):S23-S29.
16. Noda N., Tani H., Morita N., Kurata S., Nakamura K., Kanagawa T., et al. Estimation of single-nucleotide polymorphism allele frequency by alternately binding probe competitive polymerase chain reaction. Anal Chim Acta 2008, 608:211-216.
17. Freitas Ai, Mendonca I., Brion M., Sequeira M.M., Reis R.P., Carracedo A., Brehm A. RAS gene polymorphisms, classical risk factors and the advent of coronary artery disease in the Portuguese population. BMC Cardiovasc Disord 2008, 8:15.
18. Takatsu K., Yokomaku T., Kurata S., Kanagawa T. A new approach to SNP genotyping with fluorescently labeled mononucleotides. Nucleic Acids Res 2004, 32:e60.
19. Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidylcarboxypeptidase). Nucleic Acids Res 1992, 20:1433.
20. Taniguchi I., Yamazaki T., Wagatsuma K., Kurusu T., Shimazu Y., Takikawa K., et al. The DD genotype of angiotensin converting enzyme polymorphism is a risk factor for coronary artery disease and coronary stent restenosis in Japanese patients. Jpn Cir J 2001, 65:897-900.
21. Masuo K., Katsuya T., Fu Y., Rakugi H., Ogihara T., Tuck M.L. β2- and β3-Adrenergic polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years. Circulation 2005, 111:3429-3434.
22. Vriese C.D., Perret J., Delporte C. Focus on the short- and long-term effects of ghrelin on energy homeostasis. Nutrition 2010, 26:579-584.
23. Ghoussaini M., Meyre D., Lobbens S., Charpentier G., Clement K., Charles M.A., et al. Implication of the Prol2AIa polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population. BMC Med Genet 2005, 6:11-19.
24. Keller M.P., Attie A.D. Physiological insights gained from gene expression analysis in obesity and diabetes. Annu Rev Nutr 2010, 30:341-364.
25. Heck A.L., Barroso C.S., Callie M.E., Bray M.S. Gene-nutrition interaction in human performance and exercise response. Nutrition 2004, 20:598-602.
26. Obregon A.M., Amador P., Valladares M., Weisstaub G., Burrows R., Santos J.L. Melanocortin-3 receptor gene variants: association with childhood obesity and eating behavior in Chilean families. Nutrition 2010, 26:760-765.
27. Nagase T., Aoki A., Yamamoto M., Yasuda H., Kado S., Nishikawa M., et al. Lack of association between the trp64arg mutation in the beta-3-adrenergic receptor gene and obesity in Japanese men: a longitudinal analysis. J Clin Endocr Metab 1997, 82:1284-1287.